18% GST On Isopropyl Rubbing Alcohol IP & Chlorhexidine Gluconate & Isopropyl Alcohol Solution: AAR

Bengaluru : The Karnataka Authority of Advance Ruling (AAR) ruled that 18% GST is applicable on Isopropyl rubbing alcohol IP and Chlorhexidine Gluconate and Isopropyl Alcohol solutions.

The Applicant, Ce Chem Pharmaceuticals is a private limited company manufacturing and selling different pharmaceutical formulations comprising Tablets, Capsules, Oral Liquids and Dry Syrups in India and also exporting to various countries across the globe.

The Applicant ensures that all its products meet the quality standards as specified by WHO-GMP and ISO certifications. The Applicant is also functioning under licenses issued by the Office of the Drugs Controller for the State of Karnataka.

The applicant has sought advance ruling on the issue Whether Isopropyl rubbing alcohol IP and Chlorhexidine Gluconate and Isopropyl Alcohol solution are to be classified under Chapter Heading 3004 attracting 12% GST, and if not, what would be the appropriate classification and justification for such classification.

The Coram consisting of Dr. M.P.Ravi Prasad and Mashood Ur Rehman observed that people buy hand sanitizers as an alternative to soap and for disinfecting purposes. In the present case, it is seen that the alcoholbased hand sanitizers, as the name itself suggests is to sanitize the hands and disinfect them and hence cannot be covered under Medicaments.

The AAR held that the goods covered under heading 3808 are covered entry no. 87 of Schedule III of Notification No.01/2017 Central Tax (Rate) dated June 28, 2017 and are taxable at the rate of 9% under the CGST Act. Similarly, the goods are taxable at the rate of 9% under the KGST Act.

  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework